bosentan anhydrous has been researched along with Impotence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, E; Balbay, MD; Basar, MM; Halici, Z; Karakus, E; Ugan, RA; Un, H | 1 |
| Calvert, RC; Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Sullivan, ME; Thompson, CS | 1 |
1 review(s) available for bosentan anhydrous and Impotence
| Article | Year |
|---|---|
Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists.
Topics: Animals; Antihypertensive Agents; Bosentan; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Erectile Dysfunction; Humans; Hypercholesterolemia; Hypertension; Male; Myocardial Ischemia; Neural Pathways; Nitric Oxide; Penile Erection; Risk Factors; Smoking; Sulfonamides | 2000 |
1 other study(ies) available for bosentan anhydrous and Impotence
| Article | Year |
|---|---|
Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats.
Topics: Animals; Apomorphine; Bosentan; Diabetes Mellitus, Experimental; Dopamine Agonists; Endothelin Receptor Antagonists; Endothelin-1; Erectile Dysfunction; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Penile Erection; Penis; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Tumor Necrosis Factor-alpha | 2017 |